Gastric conduit perfusion assessment by ICG fluorescence in minimally invasive esophagectomy
Completed
- Conditions
- Esophageal cancer, Fluorescence, NIRF, ICG
- Registration Number
- NL-OMON23045
- Lead Sponsor
- Radboud University Medical Center Nijmegen
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
•All patients eligible for minimally invasive esophagectomy for esophageal cancer, with gastric conduit reconstruction and intra-thoracic gastro-esophageal anastomosis
•Aged 18 years or older
Exclusion Criteria
•Known pregnancy or breastfeeding
•Known iodine, shellfish or ICG hypersensitivity
Study & Design
- Study Type
- Not specified
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To explore the feasibility and added value of intra-operative NIRF imaging to assess gastric conduit perfusion in minimally invasive esophagectomy.
- Secondary Outcome Measures
Name Time Method Indentify the increase in procedure time, post-operative anastomotic leakage, patient and tumor characteristics <br>